Molecular Neurodegeneration

Scope & Guideline

Empowering research in molecular neuroscience.

Introduction

Welcome to your portal for understanding Molecular Neurodegeneration, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationMOL NEURODEGENER / Mol. Neurodegener.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

Molecular Neurodegeneration focuses on the molecular and cellular mechanisms underlying neurodegenerative diseases, providing a platform for research that integrates various aspects of neurobiology and pathology.
  1. Mechanistic Insights into Neurodegeneration:
    The journal emphasizes understanding the fundamental biological processes that lead to neurodegenerative diseases, such as Alzheimer's, Parkinson's, and other tauopathies. This includes studies on protein misfolding, aggregation, and cellular stress responses.
  2. Immune System Interactions:
    Research often explores the role of the immune system, including microglial activation, neuroinflammation, and the effects of immune modulation on neurodegeneration, highlighting the complex interplay between the nervous and immune systems.
  3. Genetic and Epigenetic Factors:
    The journal covers genetic studies, including genome-wide association studies (GWAS) and investigations into specific genetic variants that contribute to neurodegenerative conditions, as well as epigenetic mechanisms that influence disease progression.
  4. Therapeutic Approaches and Biomarkers:
    Molecular Neurodegeneration presents studies on novel therapeutic strategies, including drug development, immunotherapy, and biomarker identification, aimed at improving diagnosis and treatment outcomes for neurodegenerative diseases.
  5. Cellular and Animal Models:
    The use of advanced cellular and animal models to study disease mechanisms and test therapeutic interventions is a consistent theme, allowing for a better understanding of human neurodegenerative conditions.
Recent publications in Molecular Neurodegeneration highlight several emerging themes that reflect the evolving landscape of neurodegenerative research.
  1. Role of the Gut-Brain Axis:
    There is an increasing focus on the gut microbiome's influence on neurodegeneration, particularly how gut-derived metabolites and inflammation affect brain health and disease progression.
  2. Single-Cell and Multi-Omics Approaches:
    The application of single-cell sequencing and multi-omics strategies is gaining traction, enabling researchers to dissect cellular heterogeneity and molecular pathways involved in neurodegenerative diseases.
  3. Targeted Protein Degradation:
    Emerging strategies involving targeted protein degradation technologies (e.g., AUTOTAC) are being explored as potential therapeutic approaches for clearing pathological protein aggregates.
  4. Advances in RNA Therapeutics:
    Research on RNA-based therapies, including antisense oligonucleotides and RNA modulation techniques, is on the rise, reflecting a shift towards innovative therapeutic modalities.
  5. Neuroinflammation and Microglial Function:
    A significant trend is the deeper exploration of neuroinflammation and the diverse roles of microglia in neurodegeneration, including their contributions to disease progression and potential as therapeutic targets.

Declining or Waning

While certain themes remain strong, others appear to be declining in prominence, reflecting shifts in research focus within the field of neurodegeneration.
  1. Traditional Neuropathology Studies:
    There seems to be a reduced emphasis on classical histopathological studies of neurodegenerative diseases, as research increasingly favors molecular and genetic approaches.
  2. Simple Model Systems:
    The use of basic model organisms or systems that do not adequately recapitulate human disease pathology appears to be waning, with a shift towards more complex models that better mimic human neurodegenerative processes.
  3. Generalized Biomarker Research:
    Research focused solely on generalized biomarkers without specific context or mechanistic insights is becoming less common, as the field moves towards more targeted and disease-specific biomarker studies.
  4. Broad Immunotherapy Approaches:
    There is a noticeable decline in publications focusing on broad-spectrum immunotherapies, with a shift towards more specific and mechanism-based immunomodulatory strategies.

Similar Journals

FEBS Journal

Your Gateway to Cutting-Edge Research in Life Sciences
Publisher: WILEYISSN: 1742-464XFrequency: 24 issues/year

FEBS Journal is a prestigious, peer-reviewed publication dedicated to advancing the field of biochemistry, cell biology, and molecular biology. Published by WILEY in the United Kingdom, this journal boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple relevant categories, including Biochemistry, Cell Biology, and Molecular Biology, reflecting its significant contribution to scientific research. With an ISSN of 1742-464X and an E-ISSN of 1742-4658, the FEBS Journal publishes original research and comprehensive reviews that push the boundaries of knowledge and innovation in the biosciences. As a vital resource for researchers, professionals, and students alike, the journal offers Open Access options, ensuring that cutting-edge discoveries are accessible to a broad audience. With a publication history converging from 2005 to the present and a robust emphasis on high-quality scholarly work, the FEBS Journal remains an essential platform for the dissemination of significant findings and advancements in the life sciences.

NEUROMOLECULAR MEDICINE

Bridging Molecular Insights and Neurological Innovations
Publisher: HUMANA PRESS INCISSN: 1535-1084Frequency: 4 issues/year

NEUROMOLECULAR MEDICINE, published by HUMANA PRESS INC, is a prestigious peer-reviewed journal dedicated to advancing the fields of cellular and molecular neuroscience, molecular medicine, and neurology. With an ISSN of 1535-1084 and an E-ISSN of 1559-1174, the journal boasts a significant presence in academic research since its inception in 2002 and continues to publish cutting-edge studies through 2024. Ranked in the Q2 category for 2023 in various disciplines, including Neuroscience and Molecular Medicine, it holds impressive positions in Scopus rankings, including 41st out of 192 in Neuroscience and Neurology. Although not an open access journal, NEUROMOLECULAR MEDICINE remains invaluable for researchers, professionals, and students seeking to explore the intricate relationships between molecular mechanisms and neurological functions, thereby contributing to the scientific understanding of nervous system diseases and therapeutic innovations.

NEUROCHEMICAL RESEARCH

Transforming insights into impactful clinical practices.
Publisher: SPRINGER/PLENUM PUBLISHERSISSN: 0364-3190Frequency: 12 issues/year

NEUROCHEMICAL RESEARCH, published by Springer/Plenum Publishers, is a pivotal journal in the fields of biochemistry, neuroscience, and cellular and molecular studies. With an impressive impact factor that positions it within the prestigious Q1 category in Biochemistry and Medicine and Q2 in Cellular and Molecular Neuroscience, it provides a robust platform for the dissemination of cutting-edge research findings. Since its inception in 1976, the journal has played a crucial role in bridging the gap between neurochemical processes and neurological health, making significant contributions to our understanding of brain function and disease. Researchers and professionals are encouraged to engage with a wealth of high-quality articles that not only advance the field but also inform clinical practices. Located in the heart of New York, the journal continues to uphold its reputation as a leader in promoting innovative research that is essential for both academic and applied sciences.

Translational Neurodegeneration

Advancing the Frontiers of Neurodegenerative Research
Publisher: BMCISSN: 2047-9158Frequency: 1 issue/year

Translational Neurodegeneration, an esteemed journal in the field of neuroscience, is published by BMC and has been an open access platform since 2012, delivering high-quality research from its base in the United Kingdom. With an impressive impact factor reflecting its significant contributions, this journal focuses on critical advancements in cellular and molecular neuroscience, cognitive neuroscience, and clinical neurology, boasting a Q1 ranking across all these categories as of 2023. Researchers and professionals benefit from its extensive reach, characterized by exceptional Scopus rankings that place it in the top percentile of its field. The journal serves as a vital resource for academics and healthcare practitioners alike, aiming to bridge the gap between laboratory discoveries and clinical applications, thereby enhancing understanding and treatment of neurodegenerative diseases. With its commitment to open access, Translational Neurodegeneration ensures that its published research is accessible to a global audience, promoting collaboration and knowledge exchange within the scientific community.

NATURE NEUROSCIENCE

Exploring Innovative Insights in Neuroscience
Publisher: NATURE PORTFOLIOISSN: 1097-6256Frequency: 12 issues/year

NATURE NEUROSCIENCE is a premier journal published by NATURE PORTFOLIO, focusing on cutting-edge research in the field of neuroscience. With an esteemed impact factor that reflects its significance in the academic community, this journal occupies an exceptional place in the 2023 Q1 category for neuroscience (miscellaneous) and boasts a leading Scopus rank of #1 out of 113 in general neuroscience, placing it within the top 1st percentile. Since its inception in 1998, NATURE NEUROSCIENCE has consistently delivered high-quality, peer-reviewed articles that contribute to our understanding of the nervous system, driving innovation and scholarship across disciplines. Although it does not offer open access, the journal remains a vital resource for researchers, professionals, and students seeking to stay at the forefront of neuroscientific discovery and discussion. Its editorial commitment to excellence ensures that it continually shapes the trajectory of neuroscience research well into 2024 and beyond, making it an indispensable asset for anyone passionate about the brain and its complexities.

IUBMB LIFE

Catalyzing Breakthroughs in Biochemical Knowledge
Publisher: WILEYISSN: 1521-6543Frequency: 12 issues/year

IUBMB LIFE is a prestigious, peer-reviewed journal published by WILEY, dedicated to advancing the fields of biochemistry, molecular biology, and cell biology. With an impressive impact factor and consistently ranked in the Q1 and Q2 categories across multiple relevant disciplines—including Biochemistry, Genetics, and Clinical Biochemistry—this journal has established itself as a leading platform for disseminating innovative research and critical reviews that propel scientific discovery. The journal spans a converged publication period from 1999 to 2024, providing comprehensive insights into the dynamic landscape of biochemical research. Researchers, professionals, and students alike are invited to explore its Open Access options, ensuring that groundbreaking studies are accessible to a global audience. As it continues to shape the future of life sciences, IUBMB LIFE remains a vital resource for those seeking to enrich their understanding and contribute to these rapidly evolving fields.

ASN Neuro

Championing High-Impact Research in Neurology and Neuroscience
Publisher: FRONTIERS MEDIA SAISSN: 1759-0914Frequency: 1 issue/year

ASN Neuro is an esteemed academic journal published by Frontiers Media SA, focusing on critical advancements in the fields of neurology and neuroscience. Since its inception in 2009, it has established itself as an Open Access platform dedicated to fostering the dissemination of knowledge and research findings that address the complexities of the nervous system. With an impressive impact factor and consistently ranking in the top quartiles of its categories—Q1 in Neurology (clinical) and Q2 in Neuroscience (miscellaneous)—ASN Neuro is recognized for its high-quality publications that cater to the evolving challenges in clinical neurology and general neuroscience. Currently, it ranks 68th out of 400 journals in Clinical Neurology and 28th out of 113 in General Neuroscience, affirming its reputable position within the academic community. Researchers, professionals, and students alike are encouraged to contribute to and benefit from this impactful journal as it presents a unique opportunity to engage with cutting-edge research, innovative methodologies, and insightful reviews in the ever-evolving landscape of brain science.

JOURNAL OF MOLECULAR NEUROSCIENCE

Advancing the Frontiers of Neural Understanding
Publisher: SPRINGERNATUREISSN: 0895-8696Frequency: 9 issues/year

Journal of Molecular Neuroscience, published by SpringerNature, is a critical resource for researchers and professionals in the dynamic field of neuroscience. With ISSN 0895-8696 and E-ISSN 1559-1166, this journal has established itself as a key player since its inception in 1989, covering a range of topics within Cellular and Molecular Neuroscience and Medicine (miscellaneous). Its impressive rankings, including being placed in the Q2 quartile for Medicine and Q3 for Cellular and Molecular Neuroscience, underscore its scholarly impact, featuring innovative research that informs and advances our understanding of neural processes. The journal does not currently operate under an open-access model, providing rich, peer-reviewed content geared towards academics and professionals seeking comprehensive analyses and breakthroughs in molecular neurobiology. With a publication window extending to 2024, the Journal of Molecular Neuroscience remains dedicated to enhancing the scientific community's knowledge landscape, making it an essential reference for those passionate about unraveling the complexities of the nervous system.

Life Science Alliance

Catalyzing Breakthroughs in Molecular Biology and Health.
Publisher: LIFE SCIENCE ALLIANCE LLCISSN: Frequency: 6 issues/year

Life Science Alliance, published by LIFE SCIENCE ALLIANCE LLC, is a premier open access journal that has been making significant contributions to the fields of Biochemistry, Genetics and Molecular Biology, Ecology, Health, Toxicology and Mutagenesis, and Plant Science since its inception in 2018. With an impressive ranking in Scopus, including Q1 quartile positions and high percentiles in relevant categories, this journal is a vital resource for researchers, professionals, and students alike who seek to advance knowledge and innovation in life sciences. The journal operates on an open access model, ensuring that research findings are freely available to the global scientific community, thereby enhancing the visibility and impact of published work. With a commitment to fostering collaboration and disseminating high-quality research, Life Science Alliance serves as an essential platform for the promotion and exchange of scientific knowledge, aiming to bridge gaps and stimulate discussions across multiple disciplines.

CELLULAR & MOLECULAR BIOLOGY LETTERS

Pioneering Research in Biochemistry and Cell Biology
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.